{
    "ticker": "SY",
    "name": "Synergy Pharmaceuticals Inc.",
    "description": "Synergy Pharmaceuticals Inc. is a biopharmaceutical company focused on developing innovative therapies for gastrointestinal diseases. Founded in 2008, Synergy is dedicated to addressing unmet medical needs in the treatment of conditions such as chronic constipation and irritable bowel syndrome. The company is best known for its lead product, plecanatide, which is designed to treat chronic idiopathic constipation (CIC) and irritable bowel syndrome with constipation (IBS-C). Synergy aims to improve the quality of life for patients by providing effective, safe, and tolerable treatment options. The company leverages its proprietary technology platform to create therapies that target and modulate gastrointestinal function. Synergy is committed to clinical research and development, with ongoing studies to further validate the efficacy and safety of its products. The company's mission is to empower patients suffering from gastrointestinal disorders by delivering breakthrough therapies that enhance their health and well-being.",
    "industry": [
        "Biotechnology",
        "Pharmaceuticals"
    ],
    "headquarters": "New York, New York, USA",
    "founded": "2008",
    "website": "https://www.synergypharma.com",
    "ceo": "Gary S. Jacob",
    "social_media": {
        "twitter": "https://twitter.com/SynergyPharma",
        "linkedin": "https://www.linkedin.com/company/synergy-pharmaceuticals-inc"
    },
    "investor_relations": "https://www.synergypharma.com/investors",
    "key_executives": [
        {
            "name": "Gary S. Jacob",
            "position": "CEO"
        },
        {
            "name": "Richard A. D. Dyer",
            "position": "CFO"
        }
    ],
    "product_categories": [
        {
            "category": "Pharmaceutical Products",
            "products": [
                "Plecanatide"
            ]
        }
    ],
    "seo": {
        "meta_title": "Synergy Pharmaceuticals Inc. | Innovative Gastrointestinal Therapies",
        "meta_description": "Explore Synergy Pharmaceuticals Inc., a biopharmaceutical company focused on developing innovative therapies for gastrointestinal diseases. Learn about their lead product, plecanatide.",
        "keywords": [
            "Synergy Pharmaceuticals",
            "Gastrointestinal Diseases",
            "Plecanatide",
            "Chronic Constipation",
            "IBS-C",
            "Biotechnology"
        ]
    },
    "faq": [
        {
            "question": "What does Synergy Pharmaceuticals specialize in?",
            "answer": "Synergy Pharmaceuticals specializes in developing therapies for gastrointestinal diseases."
        },
        {
            "question": "What is plecanatide?",
            "answer": "Plecanatide is a medication developed by Synergy for the treatment of chronic idiopathic constipation and irritable bowel syndrome with constipation."
        },
        {
            "question": "When was Synergy Pharmaceuticals founded?",
            "answer": "Synergy Pharmaceuticals was founded in 2008."
        },
        {
            "question": "Where is Synergy Pharmaceuticals headquartered?",
            "answer": "Synergy Pharmaceuticals is headquartered in New York, New York, USA."
        }
    ],
    "competitors": [
        "AMGN",
        "AZN",
        "GILD",
        "JNJ"
    ],
    "related_stocks": [
        "PFE",
        "MRK",
        "BMY",
        "ABBV"
    ]
}